Press Releases

Date Title and Summary Additional Formats
Toggle Summary "Nature Reviews Drug Discovery" Publishes New Findings on Trial Complexity Based Upon Benchmark Data from Medidata
Analysis Drawn from Medidata's PICAS Database Uncovers a Significant Increase in the Number of Distinct Procedures Impacting Both Trial Cost and Site and Patient Burden Drug Development Sponsors Can Use Data to Benchmark Against Organizational Practices and Help Optimize Protocol Design NEW YORK
View HTML
Toggle Summary Medidata Reports Record Second Quarter 2017 Results
Record revenue of $137.4 million , representing 20% year-over-year growth GAAP net income of $8.3 million , or $0.14 per diluted share, up 33% year-over-year Cash flow from operations of $38.2 million , representing 31% year-over-year growth NEW YORK --(BUSINESS WIRE)-- Medidata (NASDAQ:MDSO), the
View HTML
Toggle Summary Medidata Successfully Hosts Annual European NEXT Conference Series
Events Bring Together Industry Leaders to Examine Technology's role in Transforming Clinical Development NEW YORK --(BUSINESS WIRE)-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced the successful completion of
View HTML
Toggle Summary Worldwide Clinical Trials Selects Medidata to Streamline Clinical Site Reimbursements Across the Globe
Medidata's end-to-end Payments Cloud to help Worldwide change the CRO experience - accelerating accurate, timely payments NEW YORK --(BUSINESS WIRE)-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that after
View HTML
Toggle Summary Medidata Schedules Second Quarter Earnings Conference Call for July 18, 2017
NEW YORK --(BUSINESS WIRE)-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that it will release its second quarter 2017 financial results before the open of the market on Tuesday, July 18, 2017 .
View HTML
Toggle Summary Chugai Deploys RaveX to Modernize Post-Marketing Surveillance
Tokyo -based Pharmaceutical Company Expands Use of Medidata's Unified Technology Platform to Simplify Study Navigation, Improve Data Quality and Speed Data Entry Times NEW YORK --(BUSINESS WIRE)-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions and data analytics for
View HTML
Toggle Summary Theracos More Effectively Manages Both Data and Content with Medidata's eTMF and eTMF Archive Solutions
Medidata's collaboration platform will allow Theracos to seamlessly manage regulated content and actively maintain inspection readiness NEW YORK --(BUSINESS WIRE)-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions and data analytics for clinical research, today announced
View HTML
Toggle Summary inVentiv Health Selects Medidata Enroll®, Medidata's eConsent Platform, to Accelerate Clinical Trials
inVentiv and Medidata Partner to Expand Use of Patient-Centered Technology to Better Connect Patients, Sites and Biopharmaceutical Clients NEW YORK & BOSTON --(BUSINESS WIRE)-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research,
View HTML
Toggle Summary Median Technologies and Medidata Partner to Deliver Differentiated Image Management Services in Clinical Trials
France -based Organization to Tap into Medidata Platform to Accelerate the Development of New Medicines in Oncology Medidata Medical Imaging™ Analyzes, Captures and Manages Fastest Growing Data Source in Healthcare Industry NEW YORK & SOPHIA ANTIPOLIS, France --(BUSINESS WIRE)-- Medidata
View HTML
Toggle Summary Sponsors and CROs Rely on Analytics in Clinical Research but Are Limited to Traditional and In-House Data, Medidata Finds
Survey Results Reveal Top Challenges Facing Life Sciences Companies Today, as Well as Emerging Data Sets, Technologies and Trends to Alleviate Hurdles in Drug Development NEW YORK --(BUSINESS WIRE)-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics
View HTML

Investor Contact

Anthony D'Amico
Senior Director, Investor Relations
+1 732 767 4331
adamico@mdsol.com